Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma

INTRODUCTION: The BRAF V600E mutation is the most common genetic event occurring in papillary thyroid cancer (PTC). Recently, the possibility of using immunohistochemistry (IHC) to detect the BRAF V600E mutation has been reported. MATERIALS AND METHODS: In 140 patients with classical PTC, the status...

Descripción completa

Detalles Bibliográficos
Autores principales: Szymonek, Monika, Kowalik, Artur, Kopczyński, Janusz, Gąsior-Perczak, Danuta, Pałyga, Iwona, Walczyk, Agnieszka, Gadawska-Juszczyk, Klaudia, Płusa, Agnieszka, Mężyk, Ryszard, Chrapek, Magdalena, Góźdź, Stanisław, Kowalska, Aldona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650387/
https://www.ncbi.nlm.nih.gov/pubmed/29088832
http://dx.doi.org/10.18632/oncotarget.20451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650387/
https://www.ncbi.nlm.nih.gov/pubmed/29088832
http://dx.doi.org/10.18632/oncotarget.20451

Ejemplares similares